Confirmed: You can judge people by the company they keep
There is an old adage, “take stock of the company you keep”. As it turns out, we are more tolerant of people who have similar negative personality traits as us.
There is an old adage, “take stock of the company you keep”. While there are many reasons why we might wish to be knowledgeable about the people we associate with, a recent study gives us a potentially new reason. One that might give a few of us pause. As it turns out, we are more tolerant of people who have similar negative personality traits as us.
In the study by professors Miller, Maples-Keller and Lamkin, college students were asked to rate themselves on a series of personality traits, some positive and some negative. Ten days later they were asked to rate how they felt about other people who had those traits. The single most consistent finding was that subjects viewed other people more favorably if they shared a trait, no matter what the trait was. That is to say, if a subject had a lack of impulse control they would rate another person who shared that trait more highly than a person of typical impulse control would have.
This tendency was strongest, however, in one trait above all: antagonism. With the connection being most prominent for the the trifecta of narcissism, psychopathy, and Machiavellianism.
There are some who object to the idea that those traits are all that bad.
Now, antagonistic people didn’t claim to like these traits in other people. They rated them as traits of average likability in other people, but this was much higher than the resounding disapproval of the trait given by people who did not claim to be antagonistic. A person with a generally negative trait will tend to tolerate their own trait in others.
This information might not come as a surprise. After all, we can all think of that one couple who have an odd trait or two between them but don’t mind at all. And traits that most people might find negative, like Machiavellianism, can be viewed more favorably by others; be it by differing values or by rationalization. This, of course, might also explain why people would be attracted to others who share their most toxic tendencies; they just don’t view them as negatively as others do.
Questions remain with this data, all of the subjects self-reported their tendencies to these personality traits. Would a person who doesn’t know they are antagonistic still think of it as an average trait? Were the subjects honest? The study also only asked about likability, there was no inquiry into if they would interact with people who had those traits.
It seems that people who declare themselves to have certain personality traits view that trait more favorably in others. So, if you like people who have questionable tendencies take a good look at yourself.
That's a sharp increase from the 1960s when it took the same share of scientists an average of 35 years to drop out of academia.
- The study tracked the careers of more than 100,000 scientists over 50 years.
- The results showed career lifespans are shrinking, and fewer scientists are getting credited as the lead author on scientific papers.
- Scientists are still pursuing careers in the private sector, however there are key differences between research conducted in academia and industry.
China's rise has necessitated a global PR push. It includes influencing how the movies you watch depict China.
- China will soon overtake the U.S. as the world's largest market for films, and it is using that fact to influence how it is depicted by Hollywood.
- While Chinese investors have been interested in buying shares of studios for a while, the real power lies in deciding which movies get into China at all.
- The influence is often subtle, but may have already derailed a few careers in the name of politics.
The bold technique involves surgically implanting a so-called microneedle patch directly onto the heart.
- Heart attacks leave scar tissue on the heart, which can reduce the organ's ability to pump blood throughout the body.
- The microneedle patch aims to deliver therapeutic cells directly to the damaged tissue.
- It hasn't been tested on humans yet, but the method has shown promising signs in research on animals.
SMARTER FASTER trademarks owned by The Big Think, Inc. All rights reserved.